4-Acetylamino-N-(6-methoxybenzothiazol-2-yl)benzamide

ID: ALA2235002

PubChem CID: 5008445

Max Phase: Preclinical

Molecular Formula: C17H15N3O3S

Molecular Weight: 341.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2nc(NC(=O)c3ccc(NC(C)=O)cc3)sc2c1

Standard InChI:  InChI=1S/C17H15N3O3S/c1-10(21)18-12-5-3-11(4-6-12)16(22)20-17-19-14-8-7-13(23-2)9-15(14)24-17/h3-9H,1-2H3,(H,18,21)(H,19,20,22)

Standard InChI Key:  KEPAIMAIHQYPDC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    3.2880  -22.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2868  -23.4739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9949  -23.8828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9931  -22.2455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4826  -22.3930    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.7017  -22.6507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7043  -23.4756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917  -23.7284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9706  -23.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7878  -23.0522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1926  -22.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7802  -21.6348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5813  -22.2457    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5814  -21.4285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0098  -22.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4215  -23.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2379  -23.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6426  -22.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2250  -21.6161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4099  -21.6246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4598  -22.3169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8740  -23.0213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6912  -23.0148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4710  -23.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  7  2  0
  6  4  2  0
  4  1  1  0
  6  7  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  1 13  1  0
 13 14  1  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
M  END

Associated Targets(Human)

UBA1 Tbio Ubiquitin-like modifier-activating enzyme 1 (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 341.39Molecular Weight (Monoisotopic): 341.0834AlogP: 3.52#Rotatable Bonds: 4
Polar Surface Area: 80.32Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.41CX Basic pKa: CX LogP: 2.97CX LogD: 2.97
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -2.10

References

1. Caputo R, Calabro ML, Micale N, Schimmer AD, Ali M, Zappala M, Grasso S.  (2012)  Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents,  21  (9): [10.1007/s00044-011-9789-8]

Source